Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.

Scher, R L; Carras, A; Schwab, D; Richtsmeier, W J; Koch, W M

Scher, R L; Carras, A; Schwab, D; Richtsmeier, W J; Koch, W M.

Affiliation

Scher RL; Division of Otolaryngology-Head and Neck Surgery, Duke University Medical Center, Durham, NC, USA.

Arch Otolaryngol Head Neck Surg ; 121(11): 1271-5, 1995 Nov.

Article in En | MEDLINE | ID: mdl-7576474

Subject(s)

Antineoplastic Agents/pharmacology; Carcinoma, Squamous Cell/therapy; Cell Adhesion Molecules; Cytotoxicity, Immunologic; Head and Neck Neoplasms/therapy; Interferon-gamma/pharmacology; Killer Cells, Lymphokine-Activated/drug effects; Carcinoma, Squamous Cell/immunology; Cell Adhesion/drug effects; Cell Adhesion Molecules/drug effects; Cytotoxicity, Immunologic/drug effects; Head and Neck Neoplasms/immunology; Humans; Immunotherapy, Adoptive; Leukocytes, Mononuclear/drug effects; Recombinant Proteins/pharmacology; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Cell Adhesion Molecules / Killer Cells, Lymphokine-Activated / Interferon-gamma / Cytotoxicity, Immunologic / Head and Neck Neoplasms / Antineoplastic Agents Limits: Humans Language: En Year: 1995 Type: Article

Search on Google

XML

PubMed Links